Paediatrics

Correction: Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?

January 9, 2025 January 9, 2025

BMC Pediatr. 2025 Jan 8;25(1):16. doi: 10.1186/s12887-025-05392-3.

NO ABSTRACT

PMID:39780130 | DOI:10.1186/s12887-025-05392-3

John Joseph

JohnJAcademy.com

View all posts by John Joseph